ACADIA Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.47
|
|
Average Rating
|
3.48
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
11
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.19
|
-0.17
|
0.02
|
10.53%
|
|
2022-06-30
|
-0.25
|
-0.21
|
0.04
|
16.00%
|
|
2022-03-31
|
-0.60
|
-0.70
|
-0.10
|
-16.67%
|
|
2021-12-31
|
-0.24
|
-0.27
|
-0.03
|
-12.50%
|
|
2021-09-30
|
-0.26
|
-0.09
|
0.17
|
65.38%
|
|
2021-06-30
|
-0.30
|
-0.27
|
0.03
|
10.00%
|
|
2021-03-31
|
-0.53
|
-0.42
|
0.11
|
20.75%
|
|
2020-12-31
|
-0.47
|
-0.42
|
0.05
|
10.64%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.08
|
|
2021-12-31
|
-1.05
|
|
2020-12-31
|
-1.80
|
|
2019-12-31
|
-1.60
|
|
2018-12-31
|
-1.95
|
|
2017-12-31
|
-2.35
|
|
2016-12-31
|
-2.34
|
|
2015-12-31
|
-1.63
|
|
2014-12-31
|
-0.94
|
|
2013-12-31
|
-0.44
|
|
2012-12-31
|
-0.37
|
|
2011-12-31
|
-0.44
|
|
2010-12-31
|
0.38
|
|
2009-12-31
|
-1.17
|
|
2008-12-31
|
-1.73
|
|
2007-12-31
|
-1.60
|
|
2006-12-31
|
-1.62
|
|
2005-12-31
|
-1.54
|
|
2004-12-31
|
-1.23
|